Delivers next‑generation immune‑modulating biologics for cancer and serious disease treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Primmune Therapeutics is a biotechnology company developing novel immune‑modulating therapies designed to treat cancer and other serious diseases. The company focuses on leveraging innate and adaptive immune system pathways to create targeted biologic treatments that enhance the body’s ability to recognize and eliminate disease cells. Its therapeutic programs include engineered cytokine variants, T‑cell modulators, and other biologic agents aimed at improving efficacy while reducing side effects compared with conventional immunotherapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Primmune Therapeutics Valuations & Financials
View real-time NPM data on Primmune Therapeutics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Primmune Therapeutics
FAQ
We have answers
Primmune Therapeutics stock does not trade on public stock exchanges. Primmune Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Primmune Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Primmune Therapeutics Stock does not trade on public stock exchanges. In order to sell Primmune Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Primmune Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Primmune Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Primmune Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Primmune Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Primmune Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Primmune Therapeutics is a private company and has not had an IPO. There is currently no Primmune Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Primmune Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
